Gene expression in the aging human brain: An overview

Current Opinion in Psychiatry

Volumn 29, Issue 2, 2016, Pages 159-167

  Mohan, Adith ^a   Mather, Karen A ^a   Thalamuthu, Anbupalam ^a   Baune, Bernhard T ^b   Sachdev, Perminder S ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

gene expression; genomics; healthy brain aging; neuroinflammation; RNA; transcriptome

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; DAXX PROTEIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FRACTALKINE; HERMES ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; PROTEIN BAX; PROTEIN BCL 6; PUMA PROTEIN; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNTRANSLATED RNA;

BRAIN; CELL DAMAGE; CELL DEATH; COGNITION; CONTROLLED CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DOWN REGULATION; EARLY INTERVENTION; FRONTAL CORTEX; GENE EXPRESSION; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MEDIATOR; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTRANSMISSION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHENOTYPE; POSTCENTRAL GYRUS; POSTSYNAPTIC DENSITY; REVIEW; SENESCENCE; SUPERIOR FRONTAL GYRUS; SYNAPTIC EFFICACY; UPREGULATION; AGING; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY;

AGING; BRAIN; GENE EXPRESSION REGULATION; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84958160282     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000238     Document Type: Review

References (56)

1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009; 374:1196-1208.
2. Perluigi M, Swomley AM, Butterfield DA. Redox proteomics and the dynamic molecular landscape of the aging brain. Ageing Res Rev 2014; 13:75-89.
3. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-2117.
4. Amaducci L, Tesco G. Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 1994; 7:283-286.
5. Parker MG, Thorslund M. Health trends in the elderly population: getting better and getting worse. Gerontologist 2007; 47:150-158.
6. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6:29-32.
7. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet 2006; 7:436-448.
8. Mattick JS. Rocking the foundations of molecular genetics. Proc Natl Acad Sci U S A 2012; 109:16400-16401.
9. Carroll SB. Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution. Cell 2008; 134:25-36.
10. Consortium IHGS. Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931-945.
11. Kang HJ, Kawasawa YI, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature 2011; 478:483-489.
12. Naumova OY, Lee M, Rychkov SY, et al. Gene expression in the human brain: the current state of the study of specificity and spatiotemporal dynamics. Child Dev 2013; 84:76-88.
13. Zahn JM, Sonu R, Vogel H, et al. Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet 2006; 2:e115.
14. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006; 12:1005-1015.
15. Holmes C, CunninghamC, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009; 73:768-774.
16. Berchtold NC, Cribbs DH, Coleman PD, et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 2008; 105:15605-15610.
17. Bradt BM, Kolb WP, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med 1998; 188:431-438.
18. Mandrekar-Colucci S, Landreth GE. Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets 2010; 9:156-167.
19. Nikas JB. Inflammation and immune system activation in aging: a mathematical approach. Sci 2013; 3:3254.
20. Cribbs DH, Berchtold NC, Perreau V, et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012; 9:179.
21. Primiani CT, Ryan VH, Rao JS, et al. Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging. PLoS One 2014; 9:e110972.
22. Colantuoni C, Lipska BK, Ye T, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478:519-523.
23. Gleichmann M, Zhang Y, Wood WH 3rd, et al. Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks. Neurobiol Aging 2012; 33:205; e1-205.e18.
24. Abdouh M, Chatoo W, El Hajjar J, et al. Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons. PLoS One 2012; 7:e31870.
25. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429:883-891.
26. Hagen TM. Oxidative stress, redox imbalance, and the aging process. Antioxid Redox Signal 2003; 5:503-506.
27. Lu T, Aron L, Zullo J, et al. REST and stress resistance in ageing and Alzheimer's disease. Nature 2014; 507:448-454.
28. Ballas N, Grunseich C, Lu DD, et al. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 2005; 121:645-657.
29. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res 2012; 9:628-645.
30. Bennett DA, Schneider JA, Buchman AS, et al. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 2012; 9:646-663.
31. Pardo LM, Rizzu P, Francescatto M, et al. Regional differences in gene expression and promoter usage in aged human brains. Neurobiol Aging 2013; 34:1825-1836.
32. Morrison JH, Baxter MG. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nature reviews Neuroscience 2012; 13:240-250.
33. Nicholson DA, Yoshida R, Berry RW, et al. Reduction in size of perforated postsynaptic densities in hippocampal axospinous synapses and age-related spatial learning impairments. J Neurosci 2004; 24:7648-7653.
34. Berchtold NC, Coleman PD, Cribbs DH, et al. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging 2013; 34:1653-1661.
35. Berchtold NC, Sabbagh MN, Beach TG, et al. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol Aging 2014; 35:1961-1972.
36. Naumova OY, Palejev D, Vlasova NV, et al. Age-related changes of gene expression in the neocortex: preliminary data on RNA-Seq of the transcriptome in three functionally distinct cortical areas. Dev Psychopathol 2012; 24:1427-1442.
37. Riascos D, Nicholas A, Samaeekia R, et al. Alterations of Ca2+-responsive proteins within cholinergic neurons in aging and Alzheimer's disease. Neurobiol Aging 2014; 35:1325-1333.
38. Rice RA, Berchtold NC, Cotman CW, Green KN. Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiol Aging 2014; 35:1002-1011.
39. Djuranovic S, Nahvi A, Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012; 336:237-240.
40. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317:1220-1224.
41. Im HI, Kenny PJ. MicroRNAs in neuronal function and dysfunction. Trends Neurosci 2012; 35:325-334.
42. Earls LR, Westmoreland JJ, Zakharenko SS. Noncoding RNA regulation of synaptic plasticity and memory: implications for aging. Ageing Res Rev 2014; 17:34-42.
43. Sempere LF, Freemantle S, Pitha-Rowe I, et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004; 5:R13.
44. Beveridge NJ, Santarelli DM, Wang X, et al. Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression. Schizophr Bull 2014; 40:399-409.
45. Fenn AM, Smith KM, Lovett-Racke AE, et al. Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiol Aging 2013; 34:2748-2758.
46. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10:111-122.
47. O'Connor JC, McCusker RH, Strle K, et al. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008; 252:91-110.
48. Glass D, Vinuela A, Davies MN, et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol 2013; 14:R75.
49. Twine NA, Janitz C, Wilkins MR, Janitz M. Sequencing of hippocampal and cerebellar transcriptomes provides new insights into the complexity of gene regulation in the human brain. Neurosci Lett 2013; 541:263-268.
50. Yankner BA, Lu T, Loerch P. The aging brain. Annu Rev Pathol 2008; 3:41-66.
51. Kumar A, Gibbs JR, Beilina A, et al. Age-associated changes in gene expression in human brain and isolated neurons. Neurobiol Aging 2013; 34:1199-1209.
52. Fillman SG, Cloonan N, Catts VS, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013; 18:206-214.
53. Sibille E. Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues Clin Neurosci 2013; 15:53-65.
54. Rakofsky JJ, Ressler KJ, Dunlop BW. BDNF function as a potential mediator of bipolar disorder and posttraumatic stress disorder comorbidity. Mol Psychiatry 2012; 17:22-35.
55. Fung SJ, Fillman SG, Webster MJ, Shannon Weickert C. Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers. Schizophr Res 2014; 155:26-30.
56. Douillard-Guilloux G, Guilloux J-P, Lewis DA, Sibille E. Anticipated brain molecular aging in major depression. Am J Geriatr Psychiatry 2013; 21:450-460